Tolga Tanguler, EVP, Chief Commercial Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 471 shares at $244.41 ($115K) on 2025-03-03, disclosed to the SEC on 2025-03-05.
Open-market sale of $115k ALNY by EVP, Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $242.37 | 131 | $32K | 27.7% |
| 2 | $243.36 | 142 | $35K | 30.1% |
| 3 | $244.41 | 96 | $23K | 20.4% |
| 4 | $245.26 | 70 | $17K | 15.0% |
| 5 | $246.18 | 29 | $7K | 6.2% |
| 6 | $247.35 | 3 |
| $742 |
| 0.6% |
| Total | $243.78 avg | 471 | $115K | 100% |
| Filing → |
| ALNY | SELL | 2026-02-17 | $607K | — | Filing → |
| ALNY | SELL | 2026-01-14 | $548K | — | Filing → |
| ALNY | SELL | 2025-10-03 | $1.1M | — | Filing → |